erythrosine has been researched along with paclitaxel in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.78) | 18.7374 |
| 1990's | 1 (2.78) | 18.2507 |
| 2000's | 19 (52.78) | 29.6817 |
| 2010's | 15 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McIntosh, JR; Stemple, DL; Sweet, SC; Welsh, MJ | 1 |
| Eagles, PA; Fraylich, PE; Marya, PK; Syed, Z | 1 |
| Keith, CH; Kisaalita, WS; Wilson, MT | 1 |
| Filipeanu, CM; Klappe, K; Kok, JW; Koning, H; Müller, M; Veldman, RJ | 1 |
| Callaghan, R; Martin, C; Rothnie, A; Walker, J | 1 |
| Drinyaev, VA; Ermakova, NV; Korystov, YN; Kruglyak, EB; Kublik, LN; Levitman, MKh; Mosin, VA; Novik, TS; Shaposhnikova, VV; Sterlina, TS | 1 |
| Elliott, JI; Higgins, CF; Raguz, S | 1 |
| Foley, JD; Heath, TD; McAnulty, JF; Murphy, CJ; Reid, TW; Waller, KR | 1 |
| Haefeli, WE; Lindenmaier, H; Peters, T; Weiss, J | 1 |
| Hou, YP; Shi, WQ; Tang, GL; Tian, SJ; Wang, WH; Zhang, D; Zhu, SE | 1 |
| Bernhardt, G; Buschauer, A; Gartner, M; Giannis, A; Gross, D; Müller, C; Sarli, V | 1 |
| Koike, T; Suzuki, K | 1 |
| Banerjee, R; Huilgol, N; Preetha, A | 1 |
| Al-Abd, AM; Kim, SY; Kuh, HJ; Kun, N; Lee, JH | 1 |
| Chinn, LW; Gow, JM; Hodges, LM; Kroetz, DL | 1 |
| Adams, VR; Cho, MJ; Dong, X; Liu, Y; Mattingly, CA; Mumper, RJ; Tseng, MT | 1 |
| Höke, A; Hosmane, S; Siddique, R; Thakor, N; Yang, IH | 1 |
| Choy, E; Duan, Z; Hornicek, FJ | 1 |
| Chakravarty, G; Honer Zu Bentrup, K; Mondal, D; Roy, U | 1 |
| Choy, E; Duan, Z; Hornicek, F; Mankin, H; Schwab, J; Susa, M; Yang, C | 1 |
| Cormack, R; Gultepe, E; Jost, E; Levy, CO; Makrigiorgos, GM; Nagesha, D; Singh, S; Sridhar, S; Tada, DB | 1 |
| Ambudkar, SV; Limtrakul, P; Ohnuma, S; Pintha, K; Pitchakarn, P; Pompimon, W | 1 |
| Chiang Boey, FY; Huang, CL; Kumar, S; Loo, JS; Steele, TW; Venkatraman, SS; Widjaja, E | 1 |
| Cheng, D; Gong, F; Miao, X; Shuai, X; Wang, W | 1 |
| Bao, JQ; Bedwell, DW; Higgins, JW; Zamek-Gliszczynski, MJ | 1 |
| Capon, RJ; Chen, ZS; Huang, XC; Salim, AA; Sun, YL | 1 |
| Liu, B; Yuan, Y | 1 |
| Srinivasan, P; Vanajothi, R | 1 |
| Balupillai, A; Gunaseelan, S; Mary, B; Muthusamy, G; Prasad, NR; Ramasamy, K; Shanmugam, M | 1 |
| Mathiyazhakan, M; Pramanik, M; Sivasubramanian, K; Upputuri, PK; Wiraja, C; Xu, C | 1 |
| Chen, J; Ding, L; Duan, Y; Han, B; Li, J; Liu, L; Shen, M; Sun, Y; Wang, Q | 1 |
| Arbeiter, D; Bajer, D; Eickner, T; Grabow, N; Matschegewski, C; Schmitz, KP; Teske, M; Wulf, K | 1 |
| Aljowni, M; Ammerman, L; Chen, G; De Oliveira, MC; Lippert, AR; Nanayakkara, AK; Olengue, K; Vogel, PD; Wise, JG | 1 |
| Ando, M; Bai, J; Dai, J; Hasegawa, T; Hirose, K; Kiuchi, M; Li, M; Nishizawa, S; Oka, S; Sakai, J; Tomida, A; Tsuruo, T | 1 |
| Abe, M; Ando, M; Bai, J; Hasegawa, T; Hirose, K; Kawakami, J; Kikuchi, M; Matsubara, J; Sakai, J; Tomida, A; Tsuruo, T; Wang, J; Zhang, S | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
36 other study(ies) available for erythrosine and paclitaxel
| Article | Year |
|---|---|
Dynamics of a fluorescent calmodulin analog in the mammalian mitotic spindle at metaphase.
Topics: Alkaloids; Animals; Benzimidazoles; Calmodulin; Cell Line; Fluoresceins; Fluorescence; In Vitro Techniques; Metaphase; Mitosis; Nocodazole; Paclitaxel; Spindle Apparatus; Tubulin | 1988 |
Kinesin and tau bind to distinct sites on microtubules.
Topics: Adenylyl Imidodiphosphate; Animals; Binding Sites; Brain; Cattle; Chromatography, DEAE-Cellulose; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Fluoresceins; Kinesins; Microtubules; Molecular Weight; Paclitaxel; tau Proteins; Tubulin | 1994 |
Glutamate-induced changes in the pattern of hippocampal dendrite outgrowth: a role for calcium-dependent pathways and the microtubule cytoskeleton.
Topics: Antineoplastic Agents; Calcium; Cell Survival; Cells, Cultured; Cysteine Proteinase Inhibitors; Cytoskeleton; Dendrites; Dipeptides; Enzyme Inhibitors; Fluoresceins; Glutamic Acid; Glycoproteins; Growth Cones; Hippocampus; Imidazoles; Microscopy, Fluorescence; Microtubule Proteins; Microtubules; Neurons; Nocodazole; Paclitaxel | 2000 |
Differential expression of sphingolipids in MRP1 overexpressing HT29 cells.
Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Cell Survival; Ceramides; Colchicine; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fluoresceins; Galactosylceramides; Glucosylceramides; HT29 Cells; Humans; Immunoblotting; Immunohistochemistry; Microscopy, Confocal; Microtubules; Mitosis; Multidrug Resistance-Associated Proteins; Paclitaxel; Propionates; Quinolines; Signal Transduction; Sphingolipids; Vincristine | 2000 |
The expression of P-glycoprotein does influence the distribution of novel fluorescent compounds in solid tumour models.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Fluoresceins; Fluorescent Dyes; Humans; Microscopy, Confocal; Paclitaxel; Rhodamine 123; Spheroids, Cellular | 2003 |
Avermectins inhibit multidrug resistance of tumor cells.
Topics: Animals; Cell Division; Cell Line, Tumor; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Synergism; Fluoresceins; Fluorescence; Humans; Ivermectin; Leukemia P388; Male; Mice; Paclitaxel; Rhodamine 123; Russia; Vincristine | 2004 |
Multidrug transporter activity in lymphocytes.
Topics: Adrenergic alpha-Antagonists; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; B-Lymphocytes; Calcium Channel Blockers; Fluoresceins; Fluorescent Dyes; Lymphocytes; Mice; Mice, Knockout; Mitoxantrone; Multidrug Resistance-Associated Proteins; Paclitaxel; Prazosin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Verapamil; Xanthenes | 2004 |
Suppression of cold ischemic injury in stored kidneys by the antimicrobial peptide bactenecin.
Topics: Actins; Adenosine; Allopurinol; Animals; Antimicrobial Cationic Peptides; Cell Line; Cold Temperature; Cryopreservation; Culture Media, Serum-Free; Cytoskeleton; Dogs; Dose-Response Relationship, Drug; Female; Fluoresceins; Glutathione; Insulin; Ischemia; Kidney; Kidney Tubules; Liposomes; Membranes; Microtubules; Mitogens; Organ Preservation; Organ Preservation Solutions; Paclitaxel; Peptides, Cyclic; Permeability; Protein Binding; Raffinose; Reperfusion Injury; Stereoisomerism; Temperature; Time Factors | 2004 |
Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein.
Topics: Animals; Antimitotic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Fluoresceins; Gene Expression Regulation; Humans; Kinesins; LLC-PK1 Cells; Mice; Microscopy, Confocal; Paclitaxel; Pyrimidines; RNA, Messenger; Swine; Thiones; Tubulin | 2006 |
Improved development by Taxol pretreatment after vitrification of in vitro matured porcine oocytes.
Topics: Animals; Cell Survival; Cells, Cultured; Chromosomes; Coloring Agents; Cryopreservation; Embryonic Development; Female; Fluoresceins; Microscopy, Confocal; Microtubules; Oocytes; Oogenesis; Paclitaxel; Parthenogenesis; Rewarming; Swine | 2006 |
Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
Topics: Acridines; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cysteine; Dose-Response Relationship, Drug; Flow Cytometry; Fluoresceins; Glioblastoma; Humans; Insecticides; Kinesins; Molecular Structure; Paclitaxel; Pyrimidines; Quinazolines; Rotenone; Spindle Apparatus; Tetrahydroisoquinolines; Thiones; Time Factors; Tubulin; Tubulin Modulators; Vinblastine | 2007 |
Mammalian Sir2-related protein (SIRT) 2-mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation.
Topics: Acetylation; Analysis of Variance; Animals; Animals, Newborn; Cell Survival; Cells, Cultured; Cerebellum; Colchicine; Fluoresceins; Gene Expression Regulation, Enzymologic; Mice; Nerve Degeneration; Neurons; Paclitaxel; RNA, Small Interfering; Sirtuin 2; Sirtuins; Time Factors; Transfection; Tubulin; Tubulin Modulators; Wallerian Degeneration | 2007 |
Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Membrane Permeability; Drug Combinations; Fatty Alcohols; Female; Fluoresceins; Fluorescent Dyes; Humans; In Vitro Techniques; Liposomes; Membrane Fluidity; Membranes, Artificial; Models, Biological; Paclitaxel; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Surface-Active Agents; Uterine Cervical Neoplasms | 2007 |
Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Cell Proliferation; Cell Survival; Culture Techniques; Drug Evaluation, Preclinical; Fluoresceins; Fluorescent Dyes; Humans; Microscopy, Confocal; Neoplasms; Paclitaxel; Tumor Cells, Cultured | 2008 |
Substrate-dependent effects of human ABCB1 coding polymorphisms.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Boron Compounds; Cell Line; Cyclosporine; Fluoresceins; Gene Frequency; Haplotypes; Humans; Paclitaxel; Polymorphism, Genetic | 2008 |
Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.
Topics: Adenosine Triphosphate; Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluoresceins; Humans; Melanoma; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Xenograft Model Antitumor Assays | 2009 |
Compartmentalized microfluidic culture platform to study mechanism of paclitaxel-induced axonal degeneration.
Topics: Animals; Antineoplastic Agents, Phytogenic; Axons; Cell Count; Cells, Cultured; Embryo, Mammalian; Erythropoietin; Fluoresceins; Ganglia, Spinal; Microfluidics; Nerve Degeneration; Paclitaxel; Rats; Recombinant Proteins; Sensory Receptor Cells | 2009 |
NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance.
Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fluoresceins; Humans; Models, Chemical; Ovarian Neoplasms; Paclitaxel; Piperidines; Quinolines | 2009 |
Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Antineoplastic Agents, Phytogenic; Biological Transport; Cell Line; Chemotherapy, Adjuvant; Cyclopropanes; Dogs; Drug Resistance, Neoplasm; Drug Resistance, Viral; Fluoresceins; HIV Infections; HIV Protease Inhibitors; Indoles; Leukotriene Antagonists; Multidrug Resistance-Associated Proteins; Neoplasms; Paclitaxel; Phenylcarbamates; Propionates; Quinolines; Saquinavir; Sulfides; Sulfonamides; Time Factors; Tosyl Compounds | 2009 |
Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.
Topics: Adenosine Triphosphatases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluoresceins; Humans; Paclitaxel; Substrate Specificity; Time Factors; Verapamil | 2010 |
Chitosan film containing poly(D,L-lactic-co-glycolic acid) nanoparticles: a platform for localized dual-drug release.
Topics: Chitosan; Drug Compounding; Drug Delivery Systems; Drug Stability; Fluoresceins; Gold; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2010 |
Kuguacin J isolated from Momordica charantia leaves inhibits P-glycoprotein (ABCB1)-mediated multidrug resistance.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding Sites; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluoresceins; Humans; Molecular Structure; Momordica charantia; Paclitaxel; Plant Leaves; Prazosin; Rhodamine 123; Triterpenes; Uterine Cervical Neoplasms; Vinblastine | 2012 |
High-throughput screening of PLGA thin films utilizing hydrophobic fluorescent dyes for hydrophobic drug compounds.
Topics: Cardiovascular Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Coated Materials, Biocompatible; Coumarins; Delayed-Action Preparations; Drug Carriers; Fluoresceins; Fluorescent Dyes; High-Throughput Screening Assays; Hydrophobic and Hydrophilic Interactions; Kinetics; Lactic Acid; Magnetic Resonance Spectroscopy; Microscopy; Microscopy, Electron, Scanning; Molecular Structure; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rhodamines; Solubility; Spectrometry, Fluorescence; Spectrum Analysis, Raman; Surface Properties; Technology, Pharmaceutical; Thiazoles | 2011 |
Design of multifunctional micelle for tumor-targeted intracellular drug release and fluorescent imaging.
Topics: Animals; Antineoplastic Agents; Drug Carriers; Fluoresceins; Fluorescence Resonance Energy Transfer; Hydrogen-Ion Concentration; Mice; Mice, Nude; Micelles; Microscopy, Confocal; Neoplasms; Paclitaxel; Quantum Dots | 2012 |
Characterization of SAGE Mdr1a (P-gp), Bcrp, and Mrp2 knockout rats using loperamide, paclitaxel, sulfasalazine, and carboxydichlorofluorescein pharmacokinetics.
Topics: Administration, Oral; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Availability; Biotransformation; Brain; Fluoresceins; Gene Knockout Techniques; Genotype; Half-Life; Loperamide; Male; Metabolic Clearance Rate; Paclitaxel; Phenotype; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Sulfasalazine; Tissue Distribution | 2012 |
Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cisplatin; Diterpenes; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Fluoresceins; Humans; Laurencia; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Paclitaxel; Vinblastine | 2013 |
Self-assembled nanoparticles based on PEGylated conjugated polyelectrolyte and drug molecules for image-guided drug delivery and photodynamic therapy.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Electrolytes; Fluoresceins; Humans; Image Processing, Computer-Assisted; Nanoparticles; Paclitaxel; Photochemotherapy; Polyethylene Glycols; Reactive Oxygen Species | 2014 |
An anthraquinone derivative from Luffa acutangula induces apoptosis in human lung cancer cell line NCI-H460 through p53-dependent pathway.
Topics: Anthraquinones; Apoptosis; Ataxia Telangiectasia Mutated Proteins; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; DNA Fragmentation; Fluoresceins; Gene Expression Regulation, Neoplastic; Humans; Intracellular Space; Luffa; Lung Neoplasms; Models, Biological; Molecular Docking Simulation; Molecular Dynamics Simulation; NF-kappa B; Nuclear Proteins; Paclitaxel; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |
Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Movement; Cell Survival; Coumaric Acids; Drug Resistance, Multiple; Fluoresceins; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; KB Cells; M Phase Cell Cycle Checkpoints; Molecular Docking Simulation; Paclitaxel; Protein Conformation | 2016 |
Near-infrared light-responsive liposomal contrast agent for photoacoustic imaging and drug release applications.
Topics: Drug Liberation; Fluoresceins; Gold; Humans; Infrared Rays; Liposomes; Nanostructures; Paclitaxel; Photoacoustic Techniques | 2017 |
Temperature-Sensitive Gold Nanoparticle-Coated Pluronic-PLL Nanoparticles for Drug Delivery and Chemo-Photothermal Therapy.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Female; Fluoresceins; Gold; Humans; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Paclitaxel; Poloxamer; Polylysine; Rabbits; Temperature | 2017 |
Novel approach for a PTX/VEGF dual drug delivery system in cardiovascular applications-an innovative bulk and surface drug immobilization.
Topics: Antineoplastic Agents, Phytogenic; Cell Line; Cell Proliferation; Cell Survival; Drug Delivery Systems; Drug Liberation; Endothelial Cells; Fluoresceins; Humans; Immobilized Proteins; Paclitaxel; Polymers; Surface Properties; Vascular Endothelial Growth Factor A | 2018 |
Optimizing Targeted Inhibitors of P-Glycoprotein Using Computational and Structure-Guided Approaches.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Line, Tumor; Cell Survival; Computer-Aided Design; Dose-Response Relationship, Drug; Drug Delivery Systems; Fluoresceins; Humans; Models, Molecular; Molecular Structure; Paclitaxel; Protein Binding; Protein Conformation; Structure-Activity Relationship | 2019 |
A new taxoid from a callus culture of Taxus cuspidata as an MDR reversal agent.
Topics: Antineoplastic Agents, Phytogenic; Calcium Channel Blockers; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluoresceins; Humans; Taxoids; Taxus; Verapamil | 2006 |
Structure-activity relationships of some taxoids as multidrug resistance modulator.
Topics: Alkaloids; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Humans; Structure-Activity Relationship; Taxoids; Taxus | 2007 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |